Nadir prostate-specific antigen as a prognostic factor of 10-year cancer-specific survival of prostate cancer patients with bone metastases

Background: In Taiwan, the proportion of men with newly diagnosed bony metastatic prostate cancer (PC) is approximately 30%. The present study aims to determine the 10-year cancer-specific survival rate and clinical prognostic factors of men with newly diagnosed bone metastatic PC that were treated...

Descripció completa

Dades bibliogràfiques

Autors principals:	Chi-Feng Hung, Tsung-Wei Wang, Cheng-Kuang Yang, Yung-Cheng Yang, Yeong-Chin Jou, Yen-Chuan Ou
Format:	Artigo
Idioma:	Inglês
Publicat:	Wolters Kluwer Health/LWW 2022-01-01
Col·lecció:	Formosan Journal of Surgery
Matèries:	metastasis prognosis prostate neoplasms prostate-specific antigen
Accés en línia:	http://www.e-fjs.org/article.asp?issn=1682-606X;year=2022;volume=55;issue=5;spage=184;epage=189;aulast=Hung
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!